{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:46:08Z","timestamp":1791413168529,"version":"4.3.3"},"reference-count":27,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,7,3]],"date-time":"2002-07-03T00:00:00Z","timestamp":1025654400000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2002,7]]},"abstract":"<jats:p><jats:bold>Summary.<\/jats:bold> In 1997, the Italian Ministry of Health created a special programme for the controlled distribution of deferiprone to collect data and to evaluate its safety and effectiveness in long\u2010term use. Five hundred and thirty\u2010two thalassaemia patients from 86 treatment centres were enrolled in this programme. One hundred and eighty\u2010seven patients (32%) experienced a total of 269 events that led to a temporary interruption or, in some cases, to a discontinuation of treatment. The incidence of agranulocytosis and milder neutropenias were 0\u00b74\/100 and 2\u00b71\/100 patient\u2010years respectively. Neutropenia occurred predominantly in younger and non\u2010splenectomized patients. Transient alanine transaminase increase, gastrointestinal discomfort and arthralgia were the other most commonly reported events. Ferritin levels showed a significant decrease in time after 3\u2003years of therapy. This is the largest number of deferiprone\u2010treated patients to have been reported to date. These data show that the drug was effective in reducing serum ferritin levels and the incidence of adverse events was not greater than the frequency reported in clinical trials.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2002.03554.x","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T00:46:20Z","timestamp":1032309980000},"page":"330-336","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":177,"title":["The safety and effectiveness of deferiprone in a large\u2010scale, 3\u2010year study in Italian patients"],"prefix":"10.1111","volume":"118","author":[{"given":"Adriana","family":"Ceci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Baiardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Felisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Domenica","family":"Cappellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Carnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"De Sanctis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Galanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelio","family":"Maggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Masera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Piga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Schettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ippazio","family":"Stef\u00e0no","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Tricta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,7,3]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050584"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb06445.x"},{"key":"e_1_2_7_4_1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1182\/blood.V80.3.593.593","article-title":"Efficacy and possible adverse effects of the oral iron chelator 1,2\u2010dimethyl\u20103\u2010hydroxypyrid\u20104\u2010one (L1) in thalassemia major","volume":"80","author":"Al\u2010Refaie F.N.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1994.tb01323.x"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05274.x"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-3886(00)00092-8"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92585-2"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199812033392313"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01866.x"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1159\/000039759"},{"key":"e_1_2_7_12_1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V76.3.435.435","article-title":"Treatment of Cooley's anemia","volume":"76","author":"Fosburg M.T.","year":"1990","journal-title":"Blood"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00726.x"},{"key":"e_1_2_7_14_1","first-page":"1","article-title":"Oral iron chelation","volume":"33","author":"Hoffbrandt A.V.","year":"1996","journal-title":"Seminars in Hematology"},{"key":"e_1_2_7_15_1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1182\/blood.V91.1.295","article-title":"Long term trial of deferiprone in 51 transfusion\u2010dependent iron overloaded patients","volume":"91","author":"Hoffbrandt A.V.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008610722972"},{"key":"e_1_2_7_17_1","first-page":"496","article-title":"Oral iron chelating therapy. A single center interim report on deferiprone (L1) in thalassemia","volume":"83","author":"Mazza P.","year":"1998","journal-title":"Haematologica"},{"key":"e_1_2_7_18_1","volume-title":"The Clinical Approach to Thalassemia","author":"Modell B.","year":"1984"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1159\/000203854"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.3.739"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199504063321404"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808133390701"},{"key":"e_1_2_7_23_1","first-page":"21b","article-title":"No progression of liver fibrosis in thalassemia major during deferiprone or desferrioxomine iron chelation","volume":"92","author":"Piga A.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199717060-00006"},{"key":"e_1_2_7_25_1","volume-title":"SAS\/STAT User's Guide","author":"SAS Institute Inc.","year":"1989"},{"key":"e_1_2_7_26_1","first-page":"1712","article-title":"Iron chelation with deferiprone in patients with thalassemia","volume":"339","author":"Stella M.","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00725.x"},{"key":"e_1_2_7_28_1","first-page":"606a","article-title":"Absence of deferiprone\u2010induced hepatic fibrosis: a multi\u2010center study","volume":"96","author":"Wanless I.R.","year":"2000","journal-title":"Blood"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03554.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03554.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2002.03554.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T11:46:36Z","timestamp":1697456796000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2002.03554.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["10.1046\/j.1365-2141.2002.03554.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03554.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7]]},"assertion":[{"value":"2002-07-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}